Briefing: NY Pedestrians Freeze As SUV Flies Through Intersection And Crashes Into Buffalo Wild Wings
Strategic angle: A speeding Acura MDX launched through a New York intersection before crashing into scaffolding outside a Buffalo Wild Wings.
Briefing: Idaho leaders push for nuclear energy expansion with new task force, federal bill
Strategic angle: Idaho is taking significant steps towards expanding nuclear energy through a new task force and proposed federal legislation.
Briefing: Providence fires English after loss to St. John's
Strategic angle: Kim English's three-year tenure at Providence is over. He was fired after the loss to St. John's.
Briefing: Schertz, eyed for leap, gets new Saint Louis deal
Strategic angle: Coach Josh Schertz secures contract extension after leading Billikens to Atlantic 10 title.
Briefing: The fish were biting in ancient Alabama: Tooth found embedded in Cretaceous apex predator's neck
Strategic angle: A unique new fossil demonstrates rare evidence of direct conflict between apex predators in the Cretaceous oceans of North America.
Briefing: Ford Has Already Recalled 7.4 Million Cars This Year
Strategic angle: Ford is on track to break its own record for vehicle recalls, having already recalled 7.4 million cars in 2026.
Briefing: Amazon Prime Video's ad-free plan is getting a price hike
Strategic angle: Amazon Prime Video is raising the price of its ad-free plan in the US and adding several new features.
Wedbush Raises Price Target on Apogee Therapeutics (APGE)
Wedbush has increased its price target for Apogee Therapeutics, indicating positive market sentiment.
Briefing: IonQ (IONQ) Announces Collaboration with Applied Research Laboratory for Intelligence and Security (ARLIS)
Strategic angle: IonQ partners with ARLIS to advance quantum computing applications.
Briefing: Luka drops 51 as Lakers explode in LeBron's return
Strategic angle: Buoyed by LeBron James' return, Luka Doncic scored 51 points on a night in which the Lakers' starting five totaled 137 points, the most by a starting lineup in a regulation game since the 1970-71 season.
Briefing: Fish stocks are on the line: Climate change impacts global fishing yields
Strategic angle: Climate change is rapidly challenging the notion that there are plenty more fish in the sea, with global fish stocks under threat.
Briefing: Most Medicare Beneficiaries Affected by Plan Terminations in 2025 Have Robust Medicare Advantage Options in 2026
Strategic angle: Virtually all (98.9%) of the 2.6 million Medicare beneficiaries enrolled in a Medicare Advantage plan that terminated coverage at the end of 2025 have at least one MA-PD available in 2026.
Briefing: Actis divests Orygen to Grupo Romero
Strategic angle: Actis has successfully divested its stake in Orygen to Grupo Romero.
Briefing: Proposing simple measures to prevent industry dumping plastic pellets into the sea
Strategic angle: The presence of small plastic pellets on the beaches of Donostia and Orio highlights a concerning source of pollution from industrial microplastics.
Briefing: Here’s Why Madison Small Cap Fund Bets on AAON (AAON)
Strategic angle: An analysis of the Madison Small Cap Fund's investment strategy focusing on AAON.
Briefing: Geneticists challenge common model of how cells retain their identity
Strategic angle: A new study from Umeå University suggests that the widely accepted model of cellular identity may be flawed.
Briefing: Money coach maxes out their Roth IRA at the beginning of every year. Is this the right move for you?
Strategic angle: Exploring the benefits and drawbacks of maxing out your Roth IRA early in the year.
Briefing: These are the 5 retirement essentials you’ll want to have as you age — and how to save money on them
Strategic angle: Discover the key essentials for a secure retirement and tips on saving money.
Briefing: Hyundai’s Ioniq 5 Robotaxi Could Be Your Next Uber In Las Vegas
Strategic angle: The automaker’s autonomous vehicle subsidiary partnered with Uber to deploy its robotaxis in Las Vegas.
Epstein’s pal attempts a biotech comeback, and Prasad exits the FDA
On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit.